Procter & Gamble (NYSE:PG – Get Free Report) will likely be issuing its Q1 2026 results before the market opens on Friday, October 24th. Analysts expect Procter & Gamble to post earnings of $1.91 per share and revenue of $22.2337 billion for the quarter. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS.Investors are encouraged to explore the company’s upcoming Q1 2026 earningoverview page for the latest details on the call scheduled for Friday, October 24, 2025 at 8:30 AM ET.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same period in the prior year, the company posted $1.40 earnings per share. Procter & Gamble’s quarterly revenue was up 1.7% on a year-over-year basis. On average, analysts expect Procter & Gamble to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Procter & Gamble Stock Up 0.3%
PG stock opened at $152.12 on Thursday. The stock has a market cap of $356.03 billion, a P/E ratio of 23.37, a P/E/G ratio of 4.02 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The stock’s fifty day simple moving average is $154.73 and its two-hundred day simple moving average is $158.50. Procter & Gamble has a 1-year low of $146.96 and a 1-year high of $180.43.
Procter & Gamble Announces Dividend
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 490 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $74,592.70. Following the completion of the sale, the insider directly owned 12,616 shares in the company, valued at $1,920,533.68. The trade was a 3.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jennifer L. Davis sold 3,227 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the transaction, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. The trade was a 4.97% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by insiders.
Institutional Trading of Procter & Gamble
Several hedge funds have recently added to or reduced their stakes in PG. Brighton Jones LLC boosted its position in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after buying an additional 13,617 shares during the period. Sivia Capital Partners LLC boosted its holdings in shares of Procter & Gamble by 19.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock valued at $979,000 after buying an additional 1,016 shares in the last quarter. Scott Marsh Financial LLC purchased a new stake in Procter & Gamble in the second quarter worth about $734,000. Two Sigma Securities LLC bought a new position in Procter & Gamble during the 2nd quarter valued at approximately $689,000. Finally, Vista Investment Management boosted its stake in Procter & Gamble by 6.7% in the 2nd quarter. Vista Investment Management now owns 3,366 shares of the company’s stock worth $536,000 after purchasing an additional 212 shares in the last quarter. 65.77% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on PG. BNP Paribas Exane reduced their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a report on Friday, October 10th. UBS Group lowered their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. BNP Paribas reissued an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Finally, Raymond James Financial lowered their price objective on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $171.68.
Check Out Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Short Selling – The Pros and Cons
- Archer’s Recent String of Victories Signals a New Phase of Growth
- What is the FTSE 100 index?
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- Investing in Travel Stocks Benefits
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.